The LISI Group posted consolidated sales of €1,323.0m for the first nine months of 2024 up +8.6% compared with 2023

•  LISI AEROSPACE: business remains buoyant in all segments of the aerospace market, with growth in excess of 20%.

•  LISI AUTOMOTIVE: the ramp-up of new products partly offsets the downturn in the global automotive market, which has worsened since the start of the third quarter.

•  LISI MEDICAL: after an exceptionally high level of sales last year, business stabilized in the third quarter ; the medium-to-long-term outlook remains solid.

Consolidated sales for the first nine months of the year came to €1,323.0m, up +8.6% on the same period of 2023, and include the following items:

•  an unfavorable currency effect of - €3.9 million (0.3% of sales), mainly due to the weakening of the average US dollar rate against the euro,

•  a price effect valued at around €40.0 million, linked to the partial passthrough to customers of inflation on manufacturing costs.

Third-quarter growth was +5.9% compared with the same period last year.

Adjusted for exchange rate variations and with no scope effects, sales rose by 8.9% over the first nine months of the year, and by 6.4% in the third quarter.

OUTLOOK

Although aerospace growth will logically remain buoyant over the coming quarters, the impact of the Boeing strike will be felt by LISI AEROSPACE's business exposed to these programs. In addition, the evolution of the automotive market creates an element of uncertainty regarding the possible postponement of new projects currently in industrialization.

At this stage and at constant exchange rates, the Group still confirms the objective set on February 22, 2024 when it published its 2023 annual results, namely to improve its EBIT and generate positive Free Cash Flow.